Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Yubo International Biotech Ltd | magaa_ex321.htm |
| EX-31.2 - CERTIFICATION - Yubo International Biotech Ltd | magaa_ex312.htm |
| EX-31.1 - CERTIFICATION - Yubo International Biotech Ltd | magaa_ex311.htm |
| 10-Q - FORM 10-Q - Yubo International Biotech Ltd | magaa_10q.htm |
EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Quarterly report on Form 10-Q of Magna-Lab Inc. for the quarter ended August 31, 2020, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
|
| (1) | such Quarterly report on Form 10-Q for the quarter ended August 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
| (2) | the information contained in such Quarterly report on Form 10-Q for the quarter ended August 31, 2020 fairly presents, in all material respects, the financial condition and results of operations of Magna-Lab Inc. |
| Dated: October 20, 2020 | By: | /s/ Liu Lina |
|
|
|
| Liu Lina, Chief Financial Officer |
|